Works matching IS 02704137 AND DT 2006 AND VI 66 AND IP 3

Results: 11

Prostate cancer and genetic susceptibility: A genome scan incorporating disease aggressiveness.

Published in:

Prostate, 2006, v. 66, n. 3, p. 317, doi. 10.1002/pros.20349

By:

Janet L. Stanford;
Shannon K. McDonnell;
Danielle M. Friedrichsen;
Erin E. Carlson;
Suzanne Kolb;
Kerry Deutsch;
Marta Janer;
Lee Hood;
Elaine A. Ostrander;
Daniel J. Schaid

Publication type:

Article

A selective retinoid X receptor agonist bexarotene (LGD1069, Targretin) prevents and overcomes multidrug resistance in advanced prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 3, p. 305, doi. 10.1002/pros.20347

By:

Wan‐Ching Yen;
William W. Lamph

Publication type:

Article

Targeting of pericytes diminishes neovascularization and lymphangiogenesis in prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 3, p. 294, doi. 10.1002/pros.20346

By:

Ugur Ozerdem

Publication type:

Article

Aurora B expression directly correlates with prostate cancer malignancy and influence prostate cell proliferation.

Published in:

Prostate, 2006, v. 66, n. 3, p. 326, doi. 10.1002/pros.20345

By:

Paolo Chieffi;
Laura Cozzolino;
Annamaria Kisslinger;
Silvana Libertini;
Stefania Staibano;
Gelsomina Mansueto;
Gaetano De Rosa;
Antonia Villacci;
Mario Vitale;
Spiros Linardopoulos;
Giuseppe Portella;
Donatella Tramontano

Publication type:

Article

90K/Mac‐2 binding protein is expressed in prostate cancer and induces promatrilysin expression.

Published in:

Prostate, 2006, v. 66, n. 3, p. 283, doi. 10.1002/pros.20343

By:

Elisabeth L. Bair;
Raymond B. Nagle;
Tricia A. Ulmer;
Suzanne Laferté;
G. Tim Bowden

Publication type:

Article

Infiltration of tumor‐reactive transforming growth factor‐beta insensitive CD8+ T cells into the tumor parenchyma is associated with apoptosis and rejection of tumor cellsThe authors declare that they have no competing financial interests.

Published in:

Prostate, 2006, v. 66, n. 3, p. 235, doi. 10.1002/pros.20340

By:

Qiang Zhang;
Thomas L. Jang;
Ximing Yang;
Irwin Park;
Robert E. Meyer;
Shilajit Kundu;
Michael Pins;
Borko Javonovic;
Timothy Kuzel;
Seong‐Jin Kim;
Luk Van Parijs;
Norm Smith;
Larry Wong;
Norman M. Greenberg;
Yinglu Guo;
Chung Lee

Publication type:

Article

Genetic analysis of neuroendocrine tumor cells in prostatic carcinoma.

Published in:

Prostate, 2006, v. 66, n. 3, p. 227, doi. 10.1002/pros.20338

By:

Christian G. Sauer;
Alexandra Roemer;
Rainer Grobholz

Publication type:

Article

Adenocarcina of the mouse prostate growth inhibition by celecoxib: Downregulation of transcription factors involved in COX‐2 inhibition.

Published in:

Prostate, 2006, v. 66, n. 3, p. 257, doi. 10.1002/pros.20331

By:

Bhagavathi A. Narayanan;
Narayanan K. Narayanan;
Brian Pttman;
Bandaru S. Reddy

Publication type:

Article

Thrombin receptor expression is upregulated in prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 3, p. 273, doi. 10.1002/pros.20326

By:

Varsha Kaushal;
Manish Kohli;
Richard A. Dennis;
Eric R. Siegel;
Walter W. Chiles;
Perkins Mukunyadzi

Publication type:

Article

Bystin in perineural invasion of prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 3, p. 266, doi. 10.1002/pros.20323

By:

Gustavo E. Ayala;
Hong Dai;
Rile Li;
Michael Ittmann;
Timothy C. Thompson;
David Rowley;
Thomas M. Wheeler

Publication type:

Article

Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.

Published in:

Prostate, 2006, v. 66, n. 3, p. 248, doi. 10.1002/pros.20319

By:

Zheng Fu;
Yasuhide Kitagawa;
Ronglai Shen;
Rajal Shah;
Rohit Mehra;
Daniel Rhodes;
Peter J. Keller;
Atsushi Mizokami;
Rodney Dunn;
Arul M. Chinnaiyan;
Zhi Yao;
Evan T. Keller

Publication type:

Article